Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice
Dean T. Nardelli
Department of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Search for more papers by this authorJoshua O. Luedtke
Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison, Madison, WI, USA
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
Search for more papers by this authorErik L. Munson
Department of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Wheaton Franciscan Laboratory, Wauwatosa, WI, USA
Search for more papers by this authorThomas F. Warner
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
Search for more papers by this authorSteven M. Callister
Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, WI, USA
Search for more papers by this authorRonald F. Schell
Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison, Madison, WI, USA
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA
Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA
Search for more papers by this authorDean T. Nardelli
Department of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Search for more papers by this authorJoshua O. Luedtke
Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison, Madison, WI, USA
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
Search for more papers by this authorErik L. Munson
Department of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Wheaton Franciscan Laboratory, Wauwatosa, WI, USA
Search for more papers by this authorThomas F. Warner
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
Search for more papers by this authorSteven M. Callister
Section of Infectious Diseases, Gundersen Lutheran Medical Center, La Crosse, WI, USA
Search for more papers by this authorRonald F. Schell
Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison, Madison, WI, USA
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA
Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, USA
Search for more papers by this authorEditor: Patrick Brennan
Abstract
The immunological events leading to the development of Lyme arthritis in humans are partially understood. Much of this information has been gained by studying the course of infection of naïve or vaccinated mice with Borrelia burgdorferi. However, the Borrelia-vaccination and -infection model has not been described using the organismal parameters commonly used in the widely accepted Borrelia-infection model. This is the first comparison between the Borrelia-infection and the Borrelia-vaccination and -infection models of arthritis. Borrelia-vaccinated and -infected C3H/HeN mice develop acute inflammation comparable to that of nonvaccinated, Borrelia-infected C3H/HeN mice. The duration and severity of arthritis in Borrelia-vaccinated and -infected mice was slightly increased compared with Borrelia-infected mice. Significantly, Borrelia-vaccinated and -infected C3H/HeN mice produce interleukin-17 (IL-17), while Borrelia-infected mice that had not been previously vaccinated do not. Neutralization of IL-17 in Borrelia-vaccinated and -infected C3H/HeN mice decreased the severity of arthritis, although not to the degree we observed previously in C57BL/6 mice. Collectively, these findings show that the Borrelia-vaccination and -infection model of Lyme arthritis incorporates elements of adaptive immunity that likely have relevance to human disease, but may not be observed in Borrelia-infected C3H/HeN mice.
References
- Akin E, McHugh G, Flavell R, Fikrig E & Steere A (1999) The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild brief arthritis. Infect Immun 67: 173–181.
- Barthold SW (1996) Lyme borreliosis in the laboratory mouse. J Spirochetal Tick-Borne Dis 3: 22–44.
- Barthold SW, Moody KD, Terwilliger GA, Duray PH, Jacoby RO & Steere AC (1988) An animal model for Lyme arthritis. Ann NY Acad Sci 157: 842–846.
- Brown CR & Reiner SL (1999a) Genetic control of experimental Lyme arthritis in the absence of specific immunity. Infect Immun 67: 1967–1973.
- Brown CR & Reiner SL (1999b) Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect Immun 67: 3329–3333.
- Brown CR, Blaho VA, Fritsche KL & Loiacono CM (2006) Stat1 deficiency exacerbates carditis but not arthritis during experimental Lyme borreliosis. J Interferon Cytokine Res 26: 390–399.
- Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM & Schell RF (2003) Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 71: 3437–3442.
- Bush KA, Walker JS, Lee CS & Kirkham BW (2001) Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol 123: 487–495.
- Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F & Miossec P (2000) Contribution of interleukin-17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12: 1092–1099.
- Chen J, Field JA, Glickstein L, Molloy PJ, Huber BT & Steere AC (1999) Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum 42: 1813–1822.
- Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, DeCoster DJ, Callister SM & Schell RF (2003) Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha. Clin Diagn Lab Immun 10: 44–52.
- Codolo G, Amedei A, Steere AC et al. (2008) Borrelia burgdorferi NapA-driven Th17 cell inflammation in Lyme arthritis. Arthritis Rheum 58: 3609–3617.
- Collins C, Wolfe J, Roessner K, Shi C, Sigal LH & Budd RC (2005) Lyme arthritis synovial γδ T cells instruct dendritic cells via Fas ligand. J Immunol 175: 5656–5665.
- Croke CL, Munson EL, Lovrich SD, Christopherson JA, Remington MC, England DM, Callister SM & Schell RF (2000) Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect Immun 68: 658–663.
- De Souza MS, Smith AL, Beck DS, Terwilliger GA, Fikrig E & Barthold SW (1993) Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect Immun 61: 1814–1822.
- DuChateau BK, Munson EL, England DM, Lovrich SD, Callister SM, Jensen JR & Schell RF (1999) Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis. J Leukocyte Biol 65: 162–170.
- Gross DM, Steere AC & Huber BT (1998) T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 160: 1022–1028.
- Infante-Duarte C, Horton HF, Byrne MC & Kamradt T (2000) Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165: 6107–6115.
- Jacobs JP, Wu HJ, Benoist C & Mathis D (2009) IL-17-producing T cells can augment autoantibody-induced arthritis. P Natl Acad Sci USA 106: 21789–21794.
- Kalish RA, Leong JM & Steere AC (1993) Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 61: 2774–2779.
- Kang I, Barthold SW, Persing DH & Bockenstedt LK (1997) T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 65: 3107–3111.
- Keane-Myers A & Nickell SP (1995) Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155: 2020–2028.
- Keitel WA (1999) Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 28 (suppl 2): S118–S123.
- Knauer J, Siegemund S, Müller U, Al-Robaiy S, Kastelein RA, Alber G & Straubinger RK (2007) Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells. FEMS Immunol Med Mic 49: 353–363.
- Kotloski NJ, Nardelli DT, Heil Peterson S, Torrealba JR, Warner TF, Callister SM & Schell RF (2008) Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin Vaccine Immunol 15: 1199–1207.
- LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O & Schell RF (2009) Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease. Clin Vaccine Immunol 16: 253–259.
- Lengl-Janssen B, Strauss AF, Steere AC & Kamradt T (1994) The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med 180: 2069–2078.
- Lim LCL, England DM, DuChateau BK, Glowacki NJ, Creson JR, Lovrich SD, Callister SM, Jobe DA & Schell RF (1994) Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect Immun 62: 2825–2833.
- Lim LCL, England DM, DuChateau BK, Glowacki NJ & Schell RF (1995) Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect Immun 63: 1400–1408.
- Lovrich SD, Callister SM, Lim LCL & Schell RF (1993) Seroprotective groups among isolates of Borrelia burgdorferi. Infect Immun 61: 4367–4374.
- Matyniak JE & Reiner SL (1995) T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 181: 1251–1254.
- McKisic MD, Redmond WL & Barthold SW (2000) Cutting edge: T cell-mediated pathology in murine Lyme borreliosis. J Immunol 164: 6096–6099.
- Nakae S, Nambu A, Sudo K & Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171: 6173–6177.
- Nardelli DT, Burchill MA, England DM, Torrealba J, Callister SM & Schell RF (2004) Association of CD4+CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged interferon gamma-deficient mice treated with anti-interleukin-17 antibody. Clin Diagn Lab Immun 11: 1075–1084.
- Nardelli DT, Cloute JP, Luk KHK, Torrealba J, Warner TF, Callister SM & Schell RF (2005) CD4+ CD25+ T cells prevent arthritis associated with Borrelia vaccination and infection. Clin Diagn Lab Immun 12: 786–792.
- Nardelli DT, Callister SM & Schell RF (2008a) Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol 15: 21–34.
- Nardelli DT, Luk KHK, Kotloski NJ, Warner TF, Torrealba JR, Callister SM & Schell RF (2008b) Role of IL-17, transforming growth factor-β, and IL-6 in the development of arthritis and production of anti-OspA borreliacidal antibodies in Borrelia-vaccinated and challenged mice. FEMS Immunol Med Mic 53: 265–274.
- Niu X, He D, Zhang X, Yue T, Li N, Zhang Z, Dong C & Chen G (2010) IL-21 regulates Th17 cells in rheumatoid arthritis. Hum Immunol 71: 334–341.
- Rosé CD, Fawcett PT & Gibney KM (2001) Arthritis following recombinant osp A vaccination for Lyme disease. J Rheumatol 28: 1400–1408.
- Schmitz JL, Schell RF, Hejka A, England DM & Konick L (1998) Induction of Lyme arthritis in LSH hamsters. Infect Immun 56: 2336–2342.
- Steere AC, Schoen RT & Taylor E (1987) The clinical evolution of Lyme arthritis. Ann Intern Med 107: 725–731.
- Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J & Nepom GT (2003) Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum 48: 534–540.
- Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT & Baxter-Lowe LA (2006) Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 203: 961–971.
- Sutton CE, Lalor SJ, Sweeny CM, Brereton CF, Lavelle EC & Mills KHG (2009) Interleukin-1 and IL-23 induce innate IL-17 production from γδ T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331–341.
- Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A & Yoshida H (2006) Two-sided roles of IL-27: induction of Th1 differentiation on naïve CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177: 5377–5385.
- Yssel H, Shanafelt M-C, Sodoerberg C, Schneider PV, Anzola J & Peltz G (1991) Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 174: 593–601.